Bernadette Connaughton, Director of Editas Medicine EDIT, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $698K. The latest trade was on 06/17.

BC

BC

Bernadette Connaughton

Director

Company

Editas Medicine EDIT

First filing

23/05/09

Trades

25 trades

Buys / sales

0 / 10

12-month net buying

−$698K

Last trade

06/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	06/01	06/02	1,625 sh	$66.21	$107,591.25	−3.6%
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	05/01	05/05	1,625 sh	$63.48	$103,155	−4.1%
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	01/05	01/06	2,000 sh	$70.25	$140,500	−4.7%
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	25/12/01	25/12/01	829 sh	$71.60	$59,356.4	−1.9%
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	25/11/10	25/11/12	2,000 sh	$68.48	$136,960	−4.4%
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	25/10/01	25/10/01	2,000 sh2 trades	$75.24avg.	$150,485	−4.3%
Halozyme TherapeuticsHALO	Open-market sale10b5-1 plan	25/09/02	25/09/02	4,000 sh3 trades	$73.69avg.	$294,741.27	−7.9%